Results 41 to 50 of about 540,232 (408)
A general practitioner's guide to hematopoietic stem-cell transplantation.
Current Oncology, 2019 Hematopoietic stem-cell transplantation (hsct) is a medical procedure that consists of infusing stem cells after a short course of chemotherapy or radiotherapy, or both.
A. Bazinet, G. Popradi
semanticscholar +1 more source
Donor selection for allogenic hemopoietic stem cell transplantation: clinical and ethical considerations [PDF]
, 2017 Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for many diseases. Stem cells may be obtained from different sources: mobilized peripheral blood stem cells, bone marrow, and umbilical cord blood.
La Russa, Raffaele +5 more
core +4 more sources
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION [PDF]
Mediterranean Journal of Hematology and Infectious Diseases, 2016 Due to its negative impact in the outcome of stem cell transplant (SCT) and solid organ transplant patients (SOT) CMV has been called “the troll of transplantation”. One of the greatest advances in the management of SCT has been the introduction of the preemptive strategy.
openaire +5 more sources
EDTA‐induced pseudothrombocytopenia in hematopoietic stem cell donor
Clinical Case Reports, 2023 We herein report a case of peripheral blood stem cell transplantation (PBSCT) involving a donor with EDTA‐induced pseudothrombocytopenia (PTCP). The apheresis product was inspected for 24 h and there was no platelet clumping or thrombocytopenia.
Misato Tsubokura +17 more
doaj +1 more source
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Frontiers in Immunology, 2016 The timely reconstitution and regain of function of a donor-derived immune system is of utmost importance for the recovery and long-term survival of patients after allogeneic hematopoietic stem cell transplantation (HSCT).
J. Ogonek +6 more
semanticscholar +1 more source
Chinese Journal of Cancer, 2016 Background Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease. Identifying AML patients with t(8;21) who have a poor prognosis despite achieving remission is important for determining the best subsequent therapy.
Ya-Zhen Qin +14 more
doaj +1 more source
In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma. [PDF]
, 2017 Generation of hematopoietic stem cells (HSCs) from pluripotent stem cells (PSCs) could potentially provide unlimited HSCs for clinical transplantation, a curative treatment for numerous blood diseases.
Becker, Hans J +6 more
core +1 more source
Case Report: Clinical and Hematological Characteristics of εγδβ Thalassemia in an Italian Patient
Frontiers in Pediatrics, 2022 Introductionεγδβ thalassemia is a rare form of β-thalassemia mostly described in children originating from Northern Europe. Only anecdotic cases from the Mediterranean area are reported. The diagnosis is challenging, considering the rarity of the disease
Ilaria Fotzi +7 more
doaj +1 more source
Blood, 2017 An international expert panel, active within the European Society for Blood and Marrow Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and the International Myelodysplastic Syndromes Foundation developed ...
T. D. Witte +29 more
semanticscholar +1 more source
Pharmaceuticals, 2022 Tacrolimus (Tac) is a pivotal immunosuppressant agent used to prevent graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (alloHSCT).
Daniel N. Marco +18 more
doaj +1 more source